Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Omega-3 Fatty Acid Supplementation Improves Endothelial Function in Primary Antiphospholipid Syndrome: A Small-Scale Randomized Double-Blind Placebo-Controlled Trial

Texto completo
Autor(es):
Mostrar menos -
Felau, Sheylla M. [1] ; Sales, Lucas P. [1] ; Solis, Marina Y. [1] ; Hayashi, Ana Paula [1] ; Roschel, Hamilton [1] ; Sa-Pinto, Ana Lucia [1] ; Oliveira de Andrade, Danieli Castro [1] ; Katayama, Keyla Y. [2] ; Irigoyen, Maria Claudia [2] ; Consolim-Colombo, Fernanda [2] ; Bonfa, Eloisa [1] ; Gualano, Bruno [1] ; Benatti, Fabiana B. [3, 1]
Número total de Autores: 13
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Appl Physiol & Nutr Res Grp, Lab Assessment & Conditioning Rheumatol, Fac Med FMUSP, Sao Paulo - Brazil
[2] Univ Sao Paulo, Heart Inst InCor, Fac Med FMUSP, Sao Paulo - Brazil
[3] Univ Estadual Campinas, UNICAMP, Sch Appl Sci, Limeira - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: FRONTIERS IN IMMUNOLOGY; v. 9, MAR 2 2018.
Citações Web of Science: 1
Resumo

Endothelial cells are thought to play a central role in the pathogenesis of antiphospholipid syndrome (APS). Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation has been shown to improve endothelial function in a number of diseases; thus, it could be of high clinical relevance in APS. The aim of this study was to evaluate the efficacy of n-3 PUFA supplementation on endothelial function (primary outcome) of patients with primary APS (PAPS). A 16-week randomized clinical trial was conducted with 22 adult women with PAPS. Patients were randomly assigned (1:1) to receive placebo (PL, n = 11) or n-3 PUFA (omega-3, n = 11) supplementation. Before (pre) and after (post) 16 weeks of the intervention, patients were assessed for endothelial function (peripheral artery tonometry) (primary outcome). Patients were also assessed for systemic markers of endothelial cell activation, inflammatory markers, dietary intake, international normalized ratio (INR), and adverse effects. At post, omega-3 group presented significant increases in endothelial function estimates reactive hyperemia index (RHI) and logarithmic transformation of RHI (LnRHI) when compared with PL (+13 vs. -12%, rho = 0.06, ES = 0.9; and +23 vs. -22%, rho = 0.02, ES = 1.0). No changes were observed for e-selectin, vascular adhesion molecule-1, and fibrinogen levels (rho > 0.05). In addition, omega-3 group showed decreased circulating levels of interleukin-10 (-4 vs. +45%, rho = 0.04, ES = -0.9) and tumor necrosis factor (-13 vs. +0.3%, rho = 0.04, ES = -0.95) and a tendency toward a lower intercellular adhesion molecule-1 response (+3 vs. +48%, rho = 0.1, ES = -0.7) at post when compared with PL. No changes in dietary intake, INR, or self-reported adverse effects were observed. In conclusion, 16 weeks of n-3 PUFA supplementation improved endothelial function in patients with well-controlled PAPS. These results support a role of n-3 PUFA supplementation as an adjuvant therapy in APS. Registered at http://ClinicalTrials.gov as NCT01956188. (AU)

Processo FAPESP: 14/06911-8 - Influência de idade, dieta e tecido na resposta à suplementação de creatina
Beneficiário:Marina Yazigi Solis
Linha de fomento: Bolsas no Brasil - Pós-Doutorado
Processo FAPESP: 17/02546-1 - Efeitos metabólicos, fisiológicos e moleculares da interrupção do tempo sedentário em pacientes com artrite reumatoide: um estudo crossover e randomizado
Beneficiário:Fabiana Braga Benatti
Linha de fomento: Bolsas no Brasil - Pós-Doutorado